Stay updated on Prevent Early Onset AD Clinical Trial

Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevent Early Onset AD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3. This reflects a small maintenance update to the page version rather than a substantive content change.
    Difference
    0.0%
    Check dated 2026-07-03T21:59:49.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0. This is a minor version update reflected in the page footer, with no changes to the study details or visible layout.
    Difference
    0.0%
    Check dated 2026-06-26T23:47:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Recruitment status on the study page is updated to 'No longer looking for participants,' reflecting that the trial is not enrolling at this time. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading, with a site revision from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T16:35:26.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Expanded registry details, new affiliations (Washington University School of Medicine), helpful links, and IPD data-sharing policy language were added to the study record. The update also introduces drug-arm references (lecanemab, solanezumab, gantenerumab) and updated metadata such as last verified and last update dates.
    Difference
    86%
    Check dated 2026-06-05T16:28:29.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Significant portions of the study record have been removed, including institutional and investigator references, drug names, data-sharing language, and various metadata like locations and eligibility criteria. The page’s description of the DIAN-TU trial and its associated components is altered by these deletions, affecting how the study is contextualized and accessed.
    Difference
    19%
    Check dated 2026-05-29T14:00:30.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, representing a new version of the page. This appears to be a metadata update rather than a substantive change to study content.
    Difference
    0.0%
    Check dated 2026-05-15T03:11:23.000Z thumbnail image

Stay in the know with updates to Prevent Early Onset AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.